financetom
Business
financetom
/
Business
/
West Pharmaceutical Services Insider Sold Shares Worth $292,436, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
West Pharmaceutical Services Insider Sold Shares Worth $292,436, According to a Recent SEC Filing
Mar 12, 2024 9:06 AM

11:51 AM EDT, 03/12/2024 (MT Newswires) -- Chad Winters, Vice President, Chief Accounting Officer, on March 11, 2024, sold 815 shares in West Pharmaceutical Services ( WST ) for $292,436. Following the Form 4 filing with the SEC, Winters has control over a total of 1,309 shares of the company, with 1,309 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/105770/000112760224009590/xslF345X03/form4.xml

Price: 366.37, Change: +8.85, Percent Change: +2.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NexGen Energy Closes Global Equity Offering
NexGen Energy Closes Global Equity Offering
Oct 16, 2025
08:31 AM EDT, 10/16/2025 (MT Newswires) -- NexGen Energy ( NXE ) said Thursday it closed its global equity offering for gross proceeds of about 1 billion Australian dollars ($650.3 million). In the North American offering, about 33.1 million common shares were sold on a bought deal basis at 12.08 Canadian dollars ($8.60) per share for gross proceeds of about...
Dianthus Enters License Agreement for Autoimmune Drug; Shares Rise
Dianthus Enters License Agreement for Autoimmune Drug; Shares Rise
Oct 16, 2025
08:31 AM EDT, 10/16/2025 (MT Newswires) -- Dianthus Therapeutics ( DNTH ) said Thursday it has entered into a licensing agreement with Nanjing Leads Biolabs for the rights outside greater China to DNTH212, a drug candidate to treat severe autoimmune diseases. Under the terms, Dianthus will pay Leads Biolabs $30 million in upfront and near-term milestone payments plus an additional...
Precision BioLogic Acquires George King Bio-Medical
Precision BioLogic Acquires George King Bio-Medical
Oct 16, 2025
HALIFAX, NS, Oct. 16, 2025 /PRNewswire/ - Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the strategic acquisition of George King Bio-Medical, Inc., a provider of hemostasis diagnostic products with close ties to the bleeding disorders community. Since its founding more than 50 years ago, George King Bio-Medical has remained true to its purpose—helping individuals...
Mira Pharmaceuticals Says Oral Mira-55 Outperforms Injected Morphine in New Preclinical Data
Mira Pharmaceuticals Says Oral Mira-55 Outperforms Injected Morphine in New Preclinical Data
Oct 16, 2025
08:32 AM EDT, 10/16/2025 (MT Newswires) -- Mira Pharmaceuticals ( MIRA ) said Thursday that new preclinical data showed that oral administration of marijuana analog Mira-55 provided superior pain normalization and significantly reduced inflammation, outperforming injected morphine in an established animal model of inflammatory pain. These results support plans to move toward clinical development through an investigational new drug application...
Copyright 2023-2026 - www.financetom.com All Rights Reserved